Application of UPLC-Q-TOF-MS with chemometric analysis and network pharmacology for comparison of different species: Paeonia lactiflora Pall. as an example

被引:1
|
作者
Yang, Zijie [1 ]
Wen, Jinli [1 ]
Zhang, Huijie [3 ,4 ]
Liu, Meiqi [1 ]
Liu, Yi [1 ,2 ]
Sun, Lili [1 ,2 ]
Ren, Xiaoliang [1 ,2 ]
机构
[1] Tianjin Univ Tradit Chinese Med, Sch Chinese Mat Med, Tianjin 301617, Peoples R China
[2] Tianjin Key Lab Therapeut Subst Tradit Chinese Med, Tianjin 301617, Peoples R China
[3] Tianjin Acad Tradit Chinese Med, Affiliated Hosp, Dept Pharmcy, Tianjin, Peoples R China
[4] Tianjin Acad Tradit Chinese Med, Chinese Med Res Inst, Tianjin, Peoples R China
基金
中国国家自然科学基金;
关键词
PERFORMANCE LIQUID-CHROMATOGRAPHY; NEURAL-NETWORK; RADIX; ALBA; INVOLVEMENT; RUBRA; EGFR;
D O I
10.1039/d3nj05969c
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Paeonia lactiflora Pall. is a perennial herb of the buttercup family with a long history of medicinal use in China. With population migration and geographical changes, it gradually differentiates into different species, namely Paeoniae Radix Alba (PRA) and Paeoniae Radix Rubra (PRR). This study established an integrated strategy to investigate the different species of Paeonia lactiflora Pall. through ultra-high-performance liquid chromatography/quadrupole time-of-flight mass spectrometry (UPLC-Q-TOF/MS), chemometric analysis combined with network pharmacology. Firstly, a total of 36 compounds were identified using UPLC-Q-TOF/MS, mainly including monoterpene glycosides, polyphenols, and phenolic acids. Hierarchical cluster analysis (HCA) and principal component analysis (PCA) indicated that the studied samples were classified into PRA and PRR based on their species, while PRA or PRR could be classified as corresponding to geographical origins and morphological characteristics. Moreover, the orthogonal partial least squares discriminant analysis (OPLS-DA) and counter propagation artificial neural networks (CP-ANN) were applied to confirm classification results and obtain the chemical markers on different samples. Network pharmacology and molecular docking techniques demonstrated that active molecules have a higher affinity for ACTB and AKT1. The results of the content of representative components demonstrated differences between the two species. In conclusion, the methodology and results of this study provided a reliable basis for the identification and rational utilization of PRA and PRR, which were important for the appropriate clinical use and quality assurance of pharmaceutical materials.
引用
收藏
页码:8290 / 8303
页数:14
相关论文
共 50 条
  • [41] UPLC-Q-TOF-MS, network analysis, and molecular docking to investigate the effect and active ingredients of tea-seed oil against bacterial pathogens
    Duan, Yan
    Zhao, Li-Juan
    Zhou, Yan-Hui
    Zhou, Qi-Zhi
    Fang, Ai-Qing
    Huang, Yu-Ting
    Ma, Yuan
    Wang, Zhi
    Lu, Yu-Ting
    Dai, Yu-Ping
    Li, Shun-Xiang
    Li, Juan
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [42] Systematically identifying the anti-inflammatory constituents of Cimicifuga dahurica by UPLC-Q/TOF-MS combined with network pharmacology analysis
    Pang, Qian-qian
    Li, Ting
    Liu, Ling-xian
    Shi, Dan-feng
    Yao, Xin-sheng
    Li, Hai-bo
    Yu, Yang
    BIOMEDICAL CHROMATOGRAPHY, 2021, 35 (12)
  • [43] Systematically investigating the pharmacological mechanism of Dazhu Hongjingtian in the prevention and treatment of acute mountain sickness by integrating UPLC/Q-TOF-MS/MS analysis and network pharmacology
    Ou, Chunyan
    Geng, Ting
    Wang, Jiajia
    Gao, Xia
    Chen, Xialin
    Luo, Xiaoting
    Tong, Xiaoyu
    Cao, Liang
    Wang, Zhenzhong
    Xiao, Wei
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2020, 179
  • [44] Integrated UPLC/Q-TOF-MS/MS Analysis and Network Pharmacology to Reveal the Neuroprotective Mechanisms and Potential Pharmacological Ingredients of Aurantii Fructus Immaturus and Aurantii Fructus
    Qiu, Mingyang
    Zhang, Jianqing
    Wei, Wenlong
    Zhang, Yan
    Li, Mengmeng
    Bai, Yuxin
    Wang, Hanze
    Meng, Qian
    Guo, De-an
    PHARMACEUTICALS, 2024, 17 (02)
  • [45] Systematic Analysis of Anti-inflammatory Active Components in Diospyros lotus Fruit Using UPLC-Q-TOF/MS Combined with Network Pharmacology
    Zan, Lifeng
    Yang, Xiangyu
    Zhang, Lei
    Xin, Juncai
    Guo, Haiyan
    Li, Hairong
    Science and Technology of Food Industry, 2024, 45 (21) : 264 - 274
  • [46] Systematically characterize the substance basis of Jinzhen oral liquid and their pharmacological mechanism using UPLC-Q-TOF/MS combined with network pharmacology analysis
    Guo, Jing-Yan
    Wang, Dong-Mei
    Wang, Meng-Jiao
    Zhou, Jun
    Pan, Ying-Ni
    Wang, Zheng-Zhong
    Xiao, Wei
    Liu, Xiao-Qiu
    JOURNAL OF FOOD AND DRUG ANALYSIS, 2019, 27 (03) : 793 - 804
  • [47] Analysis of the permeable and retainable components of Cayratia japonica ointment through intact or broken skin after topical application by UPLC-Q-TOF-MS/MS combined with in vitro transdermal assay
    Zhao, Xuelong
    Dai, Ruixue
    Wang, Jing
    Cao, Liangliang
    Chen, Peidong
    Yao, Weifeng
    Cheng, Fangfang
    Bao, Beihua
    Zhang, Li
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2024, 238
  • [48] Exploring the effective compounds and potential mechanisms of Shengxian Decoction against coronary heart disease by UPLC-Q-TOF/MS and network pharmacology analysis
    Zhou, Hao-ming
    Yue, Shi-jun
    Wang, Wen-xiao
    Zhang, Qiao
    Xu, Ding-qiao
    Li, Jia-jia
    Tang, Yu-ping
    Yang, Xin-yu
    HELIYON, 2024, 10 (08)
  • [49] Identification of Quality Markers in Schisandra chinensis (Turcz.) Baill. Using UPLC-Q-Extractive Orbitrap/MS, Chemometric Analysis, and Network Pharmacology
    Wang, Yinpeng
    Li, Yumei
    Ding, Yan
    Du, Xinxin
    Zhu, Jingbo
    SEPARATIONS, 2024, 11 (03)
  • [50] Systematic investigation of the pharmacological mechanism for renal protection by the leaves of Eucommia ulmoides Oliver using UPLC-Q-TOF/MS combined with network pharmacology analysis
    Huang, Qi
    Zhang, Fengyu
    Liu, Shao
    Jiang, Yueping
    Ouyang, Dongsheng
    BIOMEDICINE & PHARMACOTHERAPY, 2021, 140